| Inoculum effect of β-lactam antibiotics JR Lenhard, ZP Bulman Journal of Antimicrobial Chemotherapy 74 (10), 2825-2843, 2019 | 107 | 2019 |
| High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model JR Lenhard, NM Smith, ZP Bulman, X Tao, V Thamlikitkul, BS Shin, ... Antimicrobial Agents and Chemotherapy 61 (3), 10.1128/aac. 01268-16, 2017 | 75 | 2017 |
| Therapeutic options for metallo-β-lactamase-producing enterobacterales X Tan, HS Kim, K Baugh, Y Huang, N Kadiyala, M Wences, N Singh, ... Infection and drug resistance, 125-142, 2021 | 74 | 2021 |
| Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use PJ Bergen, ZP Bulman, S Saju, JB Bulitta, C Landersdorfer, A Forrest, J Li, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (1 …, 2015 | 74 | 2015 |
| Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat DA Butler, M Biagi, X Tan, S Qasmieh, ZP Bulman, E Wenzler Current infectious disease reports 21, 1-17, 2019 | 69 | 2019 |
| Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era ZP Bulman, L Chen, TJ Walsh, MJ Satlin, Y Qian, JB Bulitta, CA Peloquin, ... MBio 8 (4), 10.1128/mbio. 00540-17, 2017 | 59* | 2017 |
| A novel property of propolis (bee glue): anti-pathogenic activity by inhibition of N-acyl-homoserine lactone mediated signaling in bacteria Z Bulman, P Le, AO Hudson, MA Savka Journal of Ethnopharmacology 138 (3), 788-797, 2011 | 54 | 2011 |
| Optimizing polymyxin combinations against resistant Gram-negative bacteria PJ Bergen, ZP Bulman, CB Landersdorfer, N Smith, JR Lenhard, ... Infectious Diseases and Therapy 4, 391-415, 2015 | 53 | 2015 |
| Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae M Zhao, ZP Bulman, JR Lenhard, MJ Satlin, BN Kreiswirth, TJ Walsh, ... Journal of Antimicrobial Chemotherapy 72 (7), 1985-1990, 2017 | 51 | 2017 |
| Shifting gears: the future of polymyxin antibiotics JR Lenhard, ZP Bulman, BT Tsuji, KS Kaye Antibiotics 8 (2), 42, 2019 | 33 | 2019 |
| A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA) I Shafiq, ZP Bulman, SL Spitznogle, JE Osorio, IS Reilly, AJ Lesse, ... Infectious Diseases 49 (5), 410-416, 2017 | 33 | 2017 |
| Rational combinations of polymyxins with other antibiotics PJ Bergen, NM Smith, TB Bedard, ZP Bulman, R Cha, BT Tsuji Polymyxin antibiotics: from laboratory bench to bedside, 251-288, 2019 | 32 | 2019 |
| Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug-resistant Stenotrophomonas maltophilia M Biagi, D Lamm, K Meyer, A Vialichka, M Jurkovic, S Patel, RE Mendes, ... Antimicrobial Agents and Chemotherapy 64 (12), 10.1128/aac. 00297-20, 2020 | 31 | 2020 |
| Genomic features associated with the degree of phenotypic resistance to carbapenems in carbapenem-resistant Klebsiella pneumoniae ZP Bulman, F Krapp, NB Pincus, E Wenzler, KR Murphy, C Qi, EA Ozer, ... Msystems 6 (5), 10.1128/msystems. 00194-21, 2021 | 29 | 2021 |
| Optimization of polymyxin B in combination with doripenem to combat mutator Pseudomonas aeruginosa NS Ly, ZP Bulman, JB Bulitta, C Baron, GG Rao, PN Holden, J Li, ... Antimicrobial agents and chemotherapy 60 (5), 2870-2880, 2016 | 28 | 2016 |
| Research priorities towards precision antibiotic therapy to improve patient care ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard, RL Nation, ... The Lancet Microbe 3 (10), e795-e802, 2022 | 27 | 2022 |
| Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype JR Lenhard, C von Eiff, IS Hong, PN Holden, MD Bear, A Suen, ... Antimicrobial Agents and Chemotherapy 59 (2), 1347-1351, 2015 | 27 | 2015 |
| Sequential evolution of vancomycin-intermediate resistance alters virulence in Staphylococcus aureus: pharmacokinetic/pharmacodynamic targets for vancomycin exposure JR Lenhard, T Brown, MJ Rybak, CJ Meaney, NB Norgard, ZP Bulman, ... Antimicrobial Agents and Chemotherapy 60 (3), 1584-1591, 2016 | 21 | 2016 |
| New polymyxin B dosing strategies to fortify old allies in the war against KPC-2-producing Klebsiella pneumoniae ZP Bulman, MJ Satlin, L Chen, BN Kreiswirth, BS Shin, TJ Walsh, ... Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02023-16, 2017 | 19 | 2017 |
| Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin ZP Bulman, NS Ly, JR Lenhard, PN Holden, JB Bulitta, BT Tsuji Antimicrobial Agents and Chemotherapy 61 (4), 10.1128/aac. 00096-16, 2017 | 19 | 2017 |
Jurgen BulittaUniversity of Florida在 bulitta.com 的电子邮件经过验证
